BioMarin Pharmaceutical Inc. Stock Chart

BioMarin Pharmaceutical Inc. (LSE) · Health Technology. stock live price and technical analysis view. Follow LSE data on Alerta Chart.

Checking data access...

About BioMarin Pharmaceutical Inc.

LSE
Market Cap
$10.64B
P/E Ratio
16.55
Shares Out.
192.01M
Sector
Health Technology
Industry
Biotechnology

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

www.biomarin.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free
0HNC.GB (0HNC.GB) Stock Live Chart & Technical Analysis | Alerta Chart | Alerta Chart